Prevention or treatment of lung diseases caused by the failure to form, or destruction of, existing alveoli, as observed in infants with bronchopulmonary dysplasia (BPD) and adults with emphysema, requires understanding of the molecular mechanisms of alveolar development. In addition to its critical role in gas exchange, the pulmonary circulation also contributes to alveolar morphogenesis and maintenance by the production of paracrine factors termed "angiocrines" that impact the development of surrounding tissue. To identify lung angiocrines that contribute to alveolar formation, we disrupted pulmonary vascular development by conditional inactivation of the Vegf-A gene during alveologenesis. This resulted in decreased pulmonary capillary and alveolar development and altered lung elastin and retinoic acid (RA) expression. We determined that RA is produced by pulmonary endothelial cells and regulates pulmonary angiogenesis and elastin synthesis by induction of VEGF-A and FGF18, respectively. Inhibition of RA synthesis in newborn mice decreased FGF18 and elastin expression and impaired alveolarization. Treatment with RA and vitamin A partially reversed the impaired vascular and alveolar development induced by VEGF inhibition. Thus, we identified RA as a lung angiocrine that regulates alveolarization through autocrine regulation of endothelial development and paracrine regulation of elastin synthesis via induction of FGF18 in mesenchymal cells.
INTRODUCTION
Disruption of lung alveolar formation or lung maintenance may lead to pulmonary diseases such as bronchopulmonary dysplasia (BPD) in premature infants and emphysema in adults, respectively (7, 30, 46, 52) . Lung histology in fatal BPD includes findings of fewer and larger alveoli with abnormal alveolar capillary structure due to arrested development, which contributes to poor gas exchange, respiratory distress and pulmonary hypertension (4, 12) .
Loss of alveoli by progressive destruction is the main histologic feature of adults with emphysema (52) . Understanding basic mechanisms of normal alveolar formation and maintenance may further identify mechanisms contributing to the pathogenesis of BPD and emphysema and lead to novel strategies to prevent and treat these diseases.
Lung morphogenesis requires complex and finely orchestrated reciprocal interactions among many cell populations comprising the airways and the alveoli, including epithelial cells, vascular cells, smooth muscle cells, fibroblasts, and other mesenchymal cells (20) .
Mechanisms of alveolarization are not completely understood, although many critical cellular and molecular factors have been identified (30, 40, 42, 46) . Of particular significance is the pulmonary vasculature, which develops in close spatial proximity to the conducting airways and the alveolar epithelium. The specific patterning of the pulmonary arteries, veins, and capillaries in relation to the airways and respiratory epithelium is essential for the gas-exchange function of the lung, and suggests interdependent development of these two lung tissue components.
Development of the pulmonary vasculature is dependent on vascular endothelial growth factor A (VEGF-A), a potent angiogenic factor essential for embryonic vascular development.
Targeted null mutation in the Vegf-A gene causes early embryonic lethality (9, 15, 58) .
Using conditional targeted inactivation of the Vegf-A gene selectively in lung epithelium, we previously showed that pulmonary vascular development during fetal lung organogenesis depends on VEGF-A produced by the epithelium, and that inhibition of pulmonary capillary formation impairs primary septation and saccular development (56) . VEGF-A is also essential for postnatal lung alveolar development and maintenance, as inhibition of VEGF-A signaling by either pharmacologic or genetic approaches causes deleterious effects on alveolar formation and structures (17, 21, 24, 25, 35, 48, 51) . However, molecular mechanisms through which impaired vascular development disrupts alveolar formation remain uncertain.
Retinoic acid (RA) is a morphogen necessary for normal lung development and can also induce lung regeneration following injury (29, 31) . The mechanisms whereby RA regulates lung development and regeneration are not well understood, but may partly be through regulation of pulmonary vascular development (1, 11) .
RA may also modulate alveolarization by regulating elastin, a key molecule in normal alveologenesis (28, 32, 33, 37, 38, 54, 57) . However, the relevant source of RA in the lungs is not clear and whether RA induces elastin directly or through intermediate molecular targets remains unknown.
Fibroblast growth factor-18 (FGF18) belongs to the FGF family, which has more than 20 members with diverse roles throughout embryonic life, including early lung development. (36, 45) . FGF signaling is necessary for normal alveolar formation, as mice deficient in both FGF receptor (FGFR) -3 and FGFR -4 exhibit impaired alveologenesis (53) . FGF18 can bind and activate both of these receptors and Fgf18 null mice die at birth with abnormal saccular development (14, 59) . However, since Fgf18 null mice die at birth, the role of FGF18 during alveolar development remains unknown. Past studies suggest that FGF18 may regulate the development and function of the smooth muscle and alveolar myofibroblast lineages as well as elastin expression, which are critical for normal septation in the lung (10, 34, 43, 55) .
We hypothesized that RA may be a VEGF-induced endothelial-derived "angiocrine" that plays a critical regulatory role in distal lung growth during the alveolar stage of postnatal development. We further hypothesized that the effects of RA on septation may be mediated through induction of FGF18 and enhanced elastin production. To test these hypotheses, we conditionally inactivated the Vegf-A gene selectively in lung epithelium during postnatal alveolar development. We show that epithelium-derived VEGF-A is essential for alveolar capillary formation and that impaired lung capillary development disrupts alveolar morphogenesis. We further demonstrated that this defect is associated with impaired elastin deposition and identified RA as an endothelium-derived factor that regulates alveolar development by autocrine regulation of endothelial cell development and paracrine induction of mesenchymal FGF18 expression and elastin expression.
MATERIALS AND METHODS
All animal procedures and protocols were reviewed and approved by the Animal Care and
Use Committees at the University of California San Francisco and the University of Colorado Denver Health Sciences Center.
Generation of Mice with Conditional and Targeted Inactivation of the Vegf-A Gene in

Lung Epithelium
Transgenic mice in which the Vegf-A gene is conditionally inactivated in lung epithelium was generated using a combination of Cre/loxP-mediated gene ablation and tetracycline (Tet)-On systems as previously reported (56 at 2 mg/ml in the drinking water, which was changed every three days, from P1 until sacrifice.
Littermates that are not tripple transgenic were used as controls.
Tissue Collection and Histology
Littermate control and triple transgenic mice were sacrificed following Dox treatment.
Excised lungs were fixed overnight in 4% paraformaldehyde prepared in phosphate-buffered saline. Samples were processed, paraffin-embedded, and sectioned (6 µm 
RNA Isolation and Quantitative Real time RT-PCR (qRT-PCR) analysis
Total RNA from postnatal lung tissue was isolated using TRIzol reagent (Invitrogen, Carlsbad, Table 1 .
Primary Lung Fibroblast Cultures
Primary mouse lung fibroblasts were isolated from lungs of 1-week-old mice as previously described (8, 27 Table 2 .
Isolation of P6 Embryonic Lung Endothelial Cells
Lungs from postnatal day 6 Tie2-EGFP mice were dissected, rinsed in PBS, minced, and digested in 1 mg/ml collagenase/dispase (Roche Applied Science, Indianapolis, IN) in PBS for 60 min at 37C. The digestion was stopped by the addition of BSA to 0.5% final concentration. The cell mixture was filtered through a 40 m cell strainer, centrifuged, washed with PBS, and resuspended to 10 7 cells/ml with PBS containing 25 mM HEPES and subjected to FACS sorting for GFP + cells.
Immortomouse-derived Lung Endothelial Cell Cultures
Lung endothelial cells derived from the immortomouse were a generous gift from Dr. Mette 
Disulfiram Treatment
To determine the effects of RA on early postnatal lung development, we treated newborn CD1 mouse pups with disulfiram on postnatal days 2 through 14. Disulfiram (Sigma, St.
Louis, MO) was dissolved in DMSO and diluted in corn oil and administered by daily intraperitoneal (ip) injections at a dose of 2.5 mg/kg/d. Control animals received ip injections of corn oil only.
Fetal PAECs isolation, cultures, and treatment
To further examine VEGF-RA interactions during lung development, PAECs were harvested from the proximal pulmonary arteries of late gestation fetal sheep at day 140 (day 147 term), as previously described (18) . Immunohistochemistry with standard endothelial markers confirmed the cell phenotype. PAECs (passage 4-5) were then exposed to ATRA, VEGF or SU5416 as described in the experiments below.
Fetal PAECs were plated in triplicate at 50,000 cells/well in DMEM with 10% FBS into 24-well plates and allowed to adhere overnight. The following day (day 0), the cells were washed twice with PBS. DMEM with 2.5% FBS with ATRA (50nM, Sigma, St. Louis, MO) or SU5416 (5μM Sigma, St. Louis, MO) was then added, and cells were incubated in 21%
oxygen. Experimental media was changed daily, and cells were counted on day 3 after removing cells with 0.25% trypsin and counted with a hemocytometer. Growth studies with treatment were performed in DMEM with 2.5% FBS, based on previous studies that determined that this was the lowest serum concentration that supported fetal PAEC survival with some proliferation (18) .
PAEC tube formation assay
To assay in vitro angiogenesis, we cross-linked rat-tail collagen using 0.2% flavin mononucleotide and a UV Stratalinker 1800 (Stratagene, La Jolla, CA). Cells (50,000 cells/well) were added in serum-free DMEM media supplemented with ATRA and SU5416, and each condition was tested in triplicate. PAECs were then incubated for 18 h under in room air. Branch-point counting was performed in blinded fashion under ×10 magnification from each of three wells with three to four fields of view per well, as previously described (18) . Wells were imaged using an Olympus IX71 fluorescence microscope (Olympus). previously been shown to be necessary for increasing the storage and delivery of vitamin A as previously described (22, 41) .
Treatment of rat pups
Animals were killed with ip pentobarbital sodium. A catheter was placed in the trachea, and the lungs were inflated with 4% paraformaldehyde and maintained at 20 cmH 2 O pressure for 60 min. A ligature was tightened around the trachea to maintain pressure, and the tracheal cannula was removed. Lungs were immersed in 4% paraformaldehyde at room temperature overnight for fixation. A 2-mm-thick transverse section was taken from the midplane of the left lobe of the fixed lungs per animal. Two sections from each animal were processed and embedded in paraffin wax for study.
Immunohistochemistry: Slides with 5-mm paraffin sections were stained with hematoxylin and eosin for assessing alveolar structures and with von Willebrand Factor (vWF), an endothelial cell-specific marker, for assessing vascular density and vascular wall thickness.
Radial alveolar counts:
Alveolarization was assessed by the radial alveolar count (RAC) method of Emery and Mithal as previously described and applied (50). Respiratory bronchioles were identified as bronchioles lined by epithelium in one part of the wall. From the center of the respiratory bronchiole, a perpendicular line was dropped to the edge of the acinus connective tissues or septum or pleura, and the number of septae intersected by this line was counted. In each animal, at least five measurements were obtained.
Pulmonary vessel density:
Pulmonary vessel density (PVD) was determined by counting vWF-stained vessels with external diameter less than 100 μm per high-power field. The fields containing large airways or vessels were avoided. At least five pulmonary vessels were measured.
Right ventricular hypertrophy:
Hearts were dissected and weighed at 14 days of age. The right ventricle (RV) and left ventricle plus septum (LV+S) were dissected and weighed, and the ratio of RV to LV+S weights was determined.
Western blot analysis for RALDH
PAEC were grown on 150-mm cloning plates with DMEM and 10% FBS. When the cells reached 90% confluence, PAEC were treated with 2.5% FBS DMEM +/-VEGF (50ng/ml) for 24 hours and cell lysates were collected, as described previously (2 analyzed after normalizing for β-actin expression.
ELISA for Retinoic Acid Measurements
PAEC were treated with VEGF (50ng/mL) or disulfiram (10uM) and lysates were collected as described above. Total protein was normalized by BCA protein assay and 8ng/well was assayed in triplicate utilizing a retinoic acid ELISA kit (Mybiosource, San Diego, CA).
Optical density measurements were collected using model 680XR microplate reader (BioRad Laboratories, Hercules, CA) and expressed as ng/ml. showed that the Vegf +/+ lungs contain numerous alveoli, whereas the Vegf SP-C-∆/∆ lungs show enlarged distal airspaces not divided by secondary septae (Fig. 1B&C) . Quantification of airspace size by mean linear intercept measurements confirmed a significant increase in airspace size in the Vegf SP-C-∆/∆ lungs (Fig. 1D) . (Fig. 1A) . In these studies, we focused our analyses on Vegf SP-C-∆/∆ lungs with the more severe phenotype. Fig. 1G ). These results demonstrate the dependence of alveolar capillary development on VEGF-A derived from the epithelium and the necessity of normal endothelial cell development for normal alveolar formation.
RESULTS
Timed deletion of the
Disrupted elastin deposition in Vegf SP-C-∆/∆ lungs
Elastin constitutes the most abundant extracellular matrix component in the lungs, forming elastic fibers that allow the tissue to stretch and recoil with respiration. Deposition of elastin by alveolar myofibroblasts is coupled to secondary septation and is critical for alveolar formation (7). We examined whether impaired alveolarization in the Vegf SP-C-∆/∆ lungs is associated with abnormality in elastin deposition. Staining for elastin in P21 lungs demonstrated that in contrast to the normal pattern of elastin deposition in alveolar walls and at the tips of alveolar septae in control lungs, elastin staining is significantly decreased in Vegf SP-C-∆/∆ lungs. Elastin was reduced in the walls of the enlarged distal airspaces and few secondary septae contained elastin at the tips ( Fig. 2A and B) . Deposition of elastin around blood vessels and airways is present in both control and Vegf SP-C-∆/∆ lungs (data not shown).
qRT-PCR confirmed decreased expression of tropoelastin mRNA in the Vegf SP-C-∆/∆ lungs (Fig. 2C ). These data demonstrate that the alveolarization defect in Vegf SP-C-∆/∆ lungs is associated with impaired elastin deposition. (Fig. 3A) ,
FGF18 and RA-synthesizing enzyme expression is reduced in Vegf SP-C-∆/∆ lungs
suggesting that the impaired elastin deposition in the Vegf SP-C-∆/∆ lungs might be due to deficiency in FGF18 expression. We next determined whether endothelial cells might be a Another factor that has been found to regulate elastin expression in the lungs is retinoic acid (28, 32, 33) . RA is a potent regulator of alveolar development, maintenance and regeneration (29, 31) . We therefore asked whether RA synthesis is disrupted in the Vegf
SP-C-
∆/∆ lungs. We examined the expression of enzymes regulating the last step of RA synthesis, the retinaldehyde dehydrogenase-1, -2, and -3 (Raldh-1, Raldh-2, and Raldh-3). qRT-PCR
showed that the expression of all these three RA-synthesizing enzymes is significantly decreased in Vegf SP-C-∆/∆ lungs compared to control lungs (Fig. 3B) . We then asked whether lung endothelial cells express these enzymes and thus are a source of RA. We isolated early postnatal endothelial cells from the lungs of Tie2-EGFP mice by FACS, and assayed for the expression of RA-synthesizing enzymes by qRT-PCR. As shown in Fig. 3C , all three Raldh enzymes are expressed at higher levels in Tie-2 EGFP-positive endothelial cells than in the EGFP-negative non-endothelial cell fraction. These results indicate that endothelial cells are a potentially significant source of RA in the developing lung.
VEGF-A regulates the expression of Raldhs and RA in pulmonary endothelial cells
We next determined if the expression of RA-synthesizing enzymes in endothelial cells is regulated by VEGF-A. We treated cultured lung endothelial cells isolated from the immortomouse with vehicle or VEGF-A at the non-permissive temperature and found that VEGF-A induced the expression of Raldh-3 mRNA to approximately 6-fold compared to vehicle-treated cells (Fig 3D) . 
Raldh-1 and
RA regulates FGF18 expression and endothelial cell proliferation
We next explored the mechanisms whereby reduced RA production might lead to impaired alveolar development. We first determined RA effects on endothelial cell proliferation. As shown in Fig. 4A&B , treatment with RA increased fetal sheep PAEC proliferation and tube formation, indicating that RA can directly stimulate angiogenesis. We asked whether this effect might be partly due to upregulation of VEGF expression by RA. As shown in Fig. 4C treatment of PAECs with RA increased VEGF protein content, suggesting that VEGF may mediate the effects of RA on angiogenesis. To test this, we treated PAECs with combination of RA and SU5416, an inhibitor of VEGF receptor tyrosine kinase. Treatment of PAECs with SU5416 alone decreased PAEC proliferation and tube formation, suggesting basal production of VEGF by PAECs (Fig. 4D&E) . Treatment of fetal PAEC with both RA and SU5416 attenuated the increase in PAEC cell proliferation and tube formation induced by RA, but does not reduce cell numbers to values observed in SU5416 treated cultures, indicating that RA likely acts through an additional mechanism besides induction of VEGF (Fig. 4D&E) .
We next asked whether the decreased FGF18 expression in the Vegf SP-C-∆/∆ lungs might be related to decreased RA. Isolated lung fibroblasts have been found to express FGF18 in vitro (10), but mechanisms underlying FGF18 expression are unknown. To determine whether RA might regulate the expression of FGF18 in lung fibroblasts, we isolated and cultured primary lung fibroblasts from early postnatal mice and found that these cells express FGF18 at baseline (Fig. 5A) . Treatment with RA dramatically induced FGF18 expression in neonatal mouse lung fibroblasts (Fig. 5B) . These results suggest that the decreased FGF18 expression found in Vegf SP-C-∆/∆ lungs might be due to deficient RA synthesis secondary to decreased expression of RA-synthesizing enzymes.
Inhibition of RA synthesis impairs alveolarization and decreases FGF18 and elastin expression
Our data suggest that RA is produced by pulmonary endothelial cells in response to VEGF and acts to regulate endothelial cell proliferation and elastin expression in fibroblasts through the induction of FGF18. A prediction of this model is that inhibition of RA synthesis would decrease lung FGF18 and elastin expression. To test this prediction, we treated newborn mice with disulfiram, a known Raldh inhibitor, during the period of alveolar development and assayed lung FGF18 and elastin expression. Disulfiram has previously been shown to block RA synthesis and impair limb growth in the developing chick, which was reversed with exogenous RA (47) . As shown in Fig. 5 , disulfiram treatment impairs alveolar development, causing enlarged distal airspaces (Fig. 5C&D) , consistent with a previous report (19) . As predicted, qRT-PCR showed reduced FGF18 and elastin mRNA levels in disulfiram-treated lungs (Fig. 5E&F) . Overall, these results demonstrate that RA synthesis is required for normal FGF18 and elastin expression during alveolar development.
Vitamin A and RA treatment reverses the effects of VEGF inhibition on alveolar development
Another prediction of our model is that RA should reverse the effects of VEGF-A inhibition on alveolar development. We tested this prediction by administering RA or RA with retinyl palmitate (RP, vitamin A) to rats that have impaired alveolar development caused by inhibition of VEGF-A signaling by treatment with SU5416, a VEGF-A receptor kinase inhibitor. As shown in Fig. 6 , SU5416 treatment of newborn rat pups caused reduced lung vessel density, decreased alveolar complexity with reduced radial alveolar counts (RAC) and right ventricular hypertrophy (RVH) (Fig. 6 A&B, D, E&F) . Treatment with RA alone did not improve lung structure in the SU5416 treated mice but did preserve vessel density (Fig. 6 D&E). Treatment with both RA and vitamin A (RP) preserved vessel density, caused a modest increase in the RAC and prevented RVH (Fig. 6 C&D, E&F) . These data indicate that the effects of VEGF-A inhibition can be partially reversed by vitamin A and RA supplementation, further supporting our concept that RA can act downstream of VEGF-A and mediate some of its effects on lung growth.
DISCUSSION
In this study, we identified several paracrine mediators associated with VEGF activity that might serve to coordinate the development of the different lung tissue components. We show that during alveolarization, epithelium-derived VEGF-A is necessary for endothelial development, and that the pulmonary vasculature may regulate mesenchymal processes essential for secondary septation through the production of RA, which stimulates endothelial cell proliferation and tube formation and modulates elastin expression by regulation of FGF18 expression in fibroblasts.
We found that inactivation of the Vegf-A gene in respiratory epithelial cells during the period of postnatal alveolar development results in defective endothelial cell development and enlarged distal airspaces. This finding is consistent with previous studies, which by using pharmacologic inhibitors of angiogenesis, inhibitors of VEGF-A signaling, or genetic manipulation of VEGF-A expression, have shown that inhibition of endothelial development impairs alveolar formation and suggested that angiocrine factors derived from the developing endothelium may contribute to normal distal airspace growth (16, 17, 21, 25, 35, 39, 48) .
Our study identified the epithelium as an essential source of VEGF-A and RA as a specific lung angiocrine that contributes to alveolar development.
Our studies show that RA may act by regulating two essential processes of alveolarization: Based on our data, we propose a model for the role of the pulmonary vasculature in alveolar formation (Fig. 7) . Epithelium-derived VEGF-A activates receptors on endothelial cells in the mesenchyme to stimulate capillary formation, which in turn produces RA that acts both as an autocrine factor regulating endothelial development (proliferation and tube formation) and 
